Skip to content
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us

Mammalian Biologics CDMO Services

Biomanufacturing Support for Your Mammalian-Derived Products

Mammalian-derived recombinant protein production represents a core capability of Cytovance Biologics. Our extensive experience, combined with our deep technical expertise, has enabled the progression of multiple complex proteins from early phase process development through scaled-up cGMP manufacturing for clinical evaluation. With a broad range of production scales up to 2000L and integrated development capabilities, we offer you both fully custom and platformed approaches to your mammalian biologic’s success.

We provide flexible end-to-end development of all ranges of complex molecules:

• Antibodies
• Fusion Proteins
• Bispecific
• TriKE
• Cytokines
• Enzymes

A 2000L Mammalian Biologics single use biorector at Cytovance Biologics.

Keep Your Molecule Moving Forward

Cytovance's mammalian CDMO services across the drug product lifecycle.

Cell Line Development

Complete mammalian clone selection, clonal stability, and banking services tailored to your requirements.

Learn More

Mammalian Process Development

Take your productivity to the next level with our process development experts.

Learn More

Mammalian Analytical Development

Robust analytical method development or transfer personalized for your mammalian-derived biologics.

Learn More

Mammalian Manufacturing

Benefit from our full-service cGMP facility from cell banks to production with up to 2,000L capacity.

Learn More

Ingenuity, On Demand

Thought Leadership from Team Cytovance

Production of Therapeutic Proteins in CHO cells

Watch Now

General Scale-Up Strategies: Commonalities Between Mammalian and Microbial Processes

Watch Now

The Power of Partnership

“We recently celebrated successful scale-up and GMP release of the first 1000L DS. We were very lucky to succeed on our first go as a byproduct of Team Cytovance’s hard work.”

— Scientist and Program Lead, Medium Biotech

Contact Us

We’re Ready to Learn About Your Project

Meet Team Cytovance in 2026!

  • – BIO Investment and Growth Summit: March 2-3, Miami Beach, FL
  • – OPCU Large Molecule: March 24, Virtual
  • – World Vaccine Congress: March 30-April 2, Washington D.C. | Booth 536
    –
    PEGS: May 11-15, Boston, MA 
  • – TIDES USA Oligonucleotide & Peptide Therapeutics: May 11-14, Boston, MA 
  • – BIO International Convention: June 22-25, San Diego, CA | Booth 4445 
  • – BioProcess International East: September 22-25, Boston, MA 
  • – CPHI Europe: October 6-8, Milan, Italy 
  • – CDMO Live Americas: October 19-21, Boston, MA 
  • – OPCU Large Molecule: October 27, Virtual
← Previous Page
Next Page →
Subscribe to our Newsletter
Unlock Ingenuity Here

Vision Statement

We believe in a healthier world where every biologic’s path to commercialization is advanced by a development and manufacturing partner that delivers ingenuity end-to-end.

  • CDMO Services
  • Your Partner
  • Knowledge Library
  • Careers
  • Contact Us

© 2026 Cytovance Biologics